Showing results (181-190 of 209) with videos related to
Sort By:
Pageof 21
Allergy|March 8, 2018
Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trialR Mösges, C Bachert, P Panzner, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 16, 2004
Characteristics of patients with seasonal allergic rhinitis and concomitant asthmaJ Bousquet, H A Boushey, W W Busse, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 25, 2006
Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responsesE M Erin, B R Leaker, A Zacharasiewicz, et al.European Journal of Immunology|February 17, 1998
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cellsS Ying, D S Robinson, Q Meng, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 20, 1998
Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitisE Minshall, O Ghaffar, L Cameron, et al.Allergy|November 8, 2014
Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individualsM H Shamji, V Bellido, G W Scadding, et al.Allergy|November 20, 2012
Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polypsP Gevaert, K T Nouri-Aria, H Wu, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 19, 2011
Immunotherapy for allergic rhinitisS M Walker, S R Durham, S J Till, et al.Allergy|January 12, 2018
Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patientsR Mösges, A F Koch, E Raskopf, et al.Allergy|July 30, 2015
Epitope specificity determines cross-protection of a SIT-induced IgG4 antibodyE Gadermaier, L K James, M H Shamji, et al.Pageof 21